Serum seeks ₹100 cr from jab volunteer
The statement follows a legal notice seeking ₹5 crore in damages sent by the advocate of a 40-year-old participant from Chennai
NEW DELHI: Serum Institute of India on Sunday said it will seek ₹100 crore in damages from a 40-year old participant in Chennai who claimed that the company’s covid-19 vaccine, which was given to him during its phase 3 trial, had caused a serious neurological side-effect.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more